Index -
P/E 22.75
EPS (ttm) 3.48
Insider Own 1.53%
Shs Outstand 100.25M
Perf Week -1.70%
Market Cap 7.92B
Forward P/E 17.94
EPS next Y 4.41
Insider Trans -0.73%
Shs Float 98.61M
Perf Month 3.20%
Income 350.80M
PEG 1.78
EPS next Q 0.94
Inst Own 99.02%
Short Float 2.50%
Perf Quarter 12.29%
Sales 4.80B
P/S 1.65
EPS this Y 9.24%
Inst Trans 3.17%
Short Ratio 3.72
Perf Half Y 23.11%
Book/sh 16.43
P/B 4.81
EPS next Y 10.89%
ROA 6.18%
Short Interest 2.47M
Perf Year 27.15%
Cash/sh 1.42
P/C 55.88
EPS next 5Y 12.77%
ROE 24.53%
52W Range 57.55 - 83.73
Perf YTD 18.59%
Dividend Est. 0.60 (0.76%)
P/FCF 29.60
EPS past 5Y 3.48%
ROI 7.74%
52W High -5.50%
Beta 0.95
Dividend TTM 0.60 (0.76%)
Quick Ratio 1.28
Sales past 5Y 2.74%
Gross Margin 19.44%
52W Low 37.49%
ATR (14) 1.55
Dividend Ex-Date Dec 29, 2023
Current Ratio 1.28
EPS Y/Y TTM 29.75%
Oper. Margin 15.24%
RSI (14) 49.44
Volatility 1.98% 1.88%
Employees 37761
Debt/Eq 1.78
Sales Y/Y TTM -1.83%
Profit Margin 7.31%
Recom 1.25
Target Price 88.36
Option/Short Yes / Yes
LT Debt/Eq 1.75
EPS Q/Q -2.14%
Payout 17.27%
Rel Volume 0.78
Prev Close 78.62
Sales Surprise 0.79%
EPS Surprise 16.41%
Sales Q/Q 9.63%
Earnings Apr 24 AMC
Avg Volume 664.55K
Price 79.12
SMA20 -1.45%
SMA50 2.68%
SMA200 13.41%
Trades
Volume 422,868
Change 0.64%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Overweight
$95
Mar-14-23 Initiated
Barclays
Equal Weight
$57
Sep-24-21 Initiated
UBS
Buy
$98
Aug-02-21 Upgrade
Raymond James
Outperform → Strong Buy
$95 → $107
Nov-23-20 Upgrade
Barclays
Equal Weight → Overweight
$96
Aug-20-20 Resumed
Barclays
Equal Weight
$71
Dec-11-19 Downgrade
Wells Fargo
Market Perform → Underperform
Oct-22-19 Resumed
Stephens
Overweight
Sep-17-19 Initiated
Deutsche Bank
Hold
$70
Sep-06-19 Upgrade
BofA/Merrill
Neutral → Buy
$73
Jun-27-19 Initiated
BMO Capital Markets
Outperform
$72
May-30-19 Upgrade
Barclays
Equal Weight → Overweight
Dec-20-18 Initiated
Jefferies
Buy
Dec-14-18 Initiated
Barclays
Equal Weight
Nov-16-18 Initiated
UBS
Buy
$86
Jul-26-18 Upgrade
Piper Jaffray
Neutral → Overweight
Mar-29-18 Resumed
Mizuho
Buy
$62
Jan-30-18 Resumed
Wells Fargo
Market Perform
Show Previous Ratings
Apr-16-24 09:40AM
Apr-10-24 04:30PM
Apr-04-24 01:37PM
Apr-03-24 04:30PM
09:45AM
04:30PM
Loading…
Apr-02-24 04:30PM
Mar-27-24 04:30PM
09:40AM
Mar-18-24 09:45AM
Mar-15-24 12:46PM
Mar-12-24 11:11AM
Mar-11-24 12:46PM
09:40AM
Mar-10-24 08:38AM
Mar-08-24 11:30AM
07:54AM
Loading…
Mar-07-24 07:54AM
Mar-05-24 07:45AM
Feb-28-24 09:19AM
Feb-27-24 12:00PM
09:40AM
Feb-23-24 09:40AM
Feb-15-24 04:30PM
Feb-14-24 09:50AM
Feb-09-24 09:13AM
04:31AM
(Thomson Reuters StreetEvents)
Feb-08-24 01:02PM
Feb-07-24 07:30PM
05:10PM
(Associated Press Finance)
04:56PM
04:30PM
04:00PM
Loading…
Feb-05-24 04:00PM
11:23AM
Jan-29-24 09:15AM
Jan-25-24 09:40AM
Jan-10-24 04:30PM
Dec-27-23 11:44AM
Dec-21-23 01:00AM
Dec-19-23 09:50AM
Dec-18-23 09:50AM
Dec-01-23 09:40AM
Nov-29-23 09:50AM
Nov-27-23 08:30AM
Nov-24-23 02:04PM
Nov-16-23 11:49AM
Nov-15-23 12:39PM
11:45AM
Nov-14-23 02:30PM
Nov-13-23 09:40AM
Oct-31-23 09:55AM
Oct-30-23 11:52AM
09:35AM
Oct-28-23 12:50PM
12:27AM
(Thomson Reuters StreetEvents)
Oct-27-23 12:03PM
Oct-26-23 07:30PM
06:12PM
06:05PM
05:00PM
(Associated Press Finance)
04:32PM
09:40AM
Oct-25-23 06:50PM
Oct-24-23 07:25AM
Oct-19-23 10:01AM
08:50AM
Oct-12-23 09:40AM
Oct-06-23 10:30AM
Oct-03-23 05:43AM
Sep-29-23 02:10PM
Sep-28-23 08:26PM
Sep-25-23 09:40AM
Sep-20-23 01:45PM
09:40AM
Sep-19-23 11:09AM
Sep-15-23 09:00AM
(American City Business Journals)
Sep-13-23 01:26PM
12:05PM
Sep-12-23 04:30PM
Sep-05-23 07:54AM
Sep-01-23 02:40PM
11:19AM
Aug-31-23 11:31AM
10:26AM
Aug-22-23 08:02AM
Aug-18-23 08:10AM
Aug-17-23 12:13PM
Aug-15-23 02:43PM
Aug-09-23 05:00AM
Aug-08-23 01:13PM
10:29AM
08:51AM
Aug-03-23 02:01PM
02:06AM
(Thomson Reuters StreetEvents)
01:31AM
Aug-01-23 07:00PM
06:15PM
05:07PM
04:30PM
Jul-23-23 08:12AM
Jul-21-23 03:08AM
Jul-20-23 08:15AM
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
COLTHARP DOUGLAS E EVP & Chief Financial Officer Nov 13 '23 Option Exercise 26.55 16,623 441,341 127,508 Nov 14 11:30 AM COLTHARP DOUGLAS E EVP & Chief Financial Officer Nov 13 '23 Sale 63.39 11,215 710,919 116,293 Nov 14 11:30 AM Charbonneau Elissa Joy Chief Medical Officer Aug 17 '23 Sale 69.58 8,294 577,097 23,081 Aug 18 11:41 AM Tarr Mark J President & CEO Aug 16 '23 Option Exercise 26.55 25,330 672,512 522,735 Aug 17 08:44 PM Tarr Mark J President & CEO Aug 16 '23 Sale 71.06 25,330 1,799,950 497,405 Aug 17 08:44 PM
Index S&P 500
P/E 12.23
EPS (ttm) 2.76
Insider Own 0.75%
Shs Outstand 466.42M
Perf Week 1.90%
Market Cap 15.48B
Forward P/E 8.40
EPS next Y 4.02
Insider Trans -0.10%
Shs Float 454.95M
Perf Month -3.07%
Income 1.31B
PEG 14.39
EPS next Q 0.78
Inst Own 96.12%
Short Float 3.97%
Perf Quarter 3.62%
Sales 12.43B
P/S 1.25
EPS this Y 1.23%
Inst Trans -0.02%
Short Ratio 3.04
Perf Half Y 31.97%
Book/sh 47.43
P/B 0.71
EPS next Y 26.86%
ROA 0.65%
Short Interest 18.07M
Perf Year 10.72%
Cash/sh -
P/C -
EPS next 5Y 0.85%
ROE 5.97%
52W Range 22.77 - 36.38
Perf YTD 1.90%
Dividend Est. 1.70 (5.04% )
P/FCF 5.75
EPS past 5Y -2.34%
ROI 3.48%
52W High -7.17%
Beta 1.36
Dividend TTM 1.68 (4.97%)
Quick Ratio -
Sales past 5Y 12.15%
Gross Margin -
52W Low 48.31%
ATR (14) 0.99
Dividend Ex-Date Jan 30, 2024
Current Ratio 0.14
EPS Y/Y TTM -33.42%
Oper. Margin 15.47%
RSI (14) 50.01
Volatility 2.83% 2.71%
Employees 17570
Debt/Eq 0.58
Sales Y/Y TTM 19.81%
Profit Margin 10.52%
Recom 2.04
Target Price 38.47
Option/Short Yes / Yes
LT Debt/Eq 0.58
EPS Q/Q -35.04%
Payout 53.71%
Rel Volume 0.89
Prev Close 32.90
Sales Surprise -0.07%
EPS Surprise -8.68%
Sales Q/Q 7.61%
Earnings Apr 17 BMO
Avg Volume 5.95M
Price 33.77
SMA20 -1.91%
SMA50 1.79%
SMA200 12.84%
Trades
Volume 4,313,199
Change 2.64%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-05-24 Upgrade
Citigroup
Neutral → Buy
$36
Jan-02-24 Downgrade
Barclays
Overweight → Equal Weight
$38 → $40
Dec-04-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$31
Oct-25-23 Downgrade
Piper Sandler
Overweight → Neutral
$29 → $26
Oct-23-23 Upgrade
Wolfe Research
Underperform → Peer Perform
Jul-10-23 Downgrade
Evercore ISI
Outperform → In-line
$32 → $29
Jun-29-23 Downgrade
JP Morgan
Overweight → Neutral
$29 → $27
Apr-20-23 Downgrade
BofA Securities
Buy → Neutral
$37 → $33
Jan-03-23 Downgrade
Wedbush
Outperform → Neutral
$45
Dec-21-22 Initiated
DA Davidson
Buy
$47
Dec-05-22 Resumed
Morgan Stanley
Overweight
$48 → $53
Sep-28-22 Resumed
Wedbush
Outperform
$44
May-16-22 Upgrade
UBS
Neutral → Buy
$48 → $54
Apr-11-22 Downgrade
Citigroup
Buy → Neutral
Apr-05-22 Downgrade
Keefe Bruyette
Outperform → Mkt Perform
$64 → $54
Mar-24-22 Resumed
Citigroup
Buy
Jan-13-22 Initiated
UBS
Neutral
$58
Jan-11-22 Upgrade
Citigroup
Neutral → Buy
$53 → $65
Jan-11-22 Resumed
Morgan Stanley
Overweight
$69
Nov-24-21 Resumed
Morgan Stanley
Overweight
$61
Show Previous Ratings
Today 07:00AM
(The Wall Street Journal)
Apr-18-24 09:20AM
03:01AM
02:45AM
(Thomson Reuters StreetEvents)
Apr-17-24 06:15PM
03:49PM
Loading…
03:49PM
01:53PM
12:07PM
10:52AM
10:30AM
(The Wall Street Journal)
09:30AM
07:51AM
07:30AM
07:24AM
06:28AM
(Associated Press Finance)
06:20AM
Loading…
06:20AM
Apr-16-24 05:04PM
08:40AM
Apr-15-24 10:00AM
05:52AM
Apr-14-24 09:30AM
Apr-12-24 09:15AM
Apr-10-24 10:00AM
Apr-02-24 12:45PM
09:01AM
Mar-27-24 08:30AM
Mar-20-24 03:00PM
Mar-11-24 11:33AM
Mar-08-24 01:45PM
09:00AM
10:34AM
Loading…
Mar-01-24 10:34AM
(The Wall Street Journal)
Feb-26-24 07:07AM
06:00AM
Feb-20-24 04:05PM
Feb-16-24 08:00AM
Feb-14-24 04:19PM
09:23AM
Feb-12-24 07:59AM
Feb-08-24 06:40PM
09:00AM
09:00AM
Feb-05-24 12:13PM
Jan-30-24 04:45PM
(Associated Press Finance)
04:35PM
09:01AM
Jan-29-24 05:05AM
Jan-24-24 08:00AM
(The Wall Street Journal)
Jan-18-24 04:47PM
11:03AM
08:11AM
01:05AM
(Thomson Reuters StreetEvents)
Jan-17-24 05:12PM
03:27PM
01:16PM
01:02PM
12:17PM
09:59AM
09:41AM
(The Wall Street Journal)
09:30AM
07:35AM
07:18AM
06:52AM
06:38AM
(Associated Press Finance)
06:20AM
Jan-16-24 05:45PM
Jan-11-24 11:54AM
Jan-10-24 11:09AM
10:00AM
09:01AM
Dec-30-23 01:07PM
Dec-29-23 01:15AM
Dec-19-23 10:58AM
Dec-18-23 04:27PM
Dec-14-23 07:10PM
12:50PM
(The Wall Street Journal)
12:43PM
11:07AM
Dec-13-23 05:49PM
(Yahoo Finance Video) +7.61%
09:01AM
Dec-12-23 09:00AM
Dec-11-23 10:39PM
Dec-07-23 03:24PM
Dec-06-23 03:39PM
Dec-05-23 12:57PM
Dec-01-23 02:00PM
Nov-27-23 04:05PM
Nov-26-23 07:00AM
(The Wall Street Journal)
Nov-23-23 12:51PM
Nov-21-23 07:01PM
Nov-17-23 03:00PM
Nov-07-23 08:28PM
04:15PM
04:05PM
12:06AM
Nov-06-23 11:54AM
Nov-05-23 12:02PM
Nov-03-23 05:00PM
08:00AM
Oct-30-23 06:13PM
09:01AM
Citizens Financial Group, Inc. engages in the provision of commercial banking services. It operates through the Consumer Banking and Commercial Banking segments. The Consumer Banking segment includes deposit products, mortgage and home equity lending, student loans, auto financing, credit cards, business loans, and wealth management and investment services. The Commercial Banking segment offers lending and leasing, trade financing, deposit and treasury management, foreign exchange and interest rate risk management, corporate finance and debt, and equity capital markets. The company was founded in 1828 and is headquartered in Providence, RI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Read Craig Jack Controller Mar 05 '24 Sale 33.54 4,508 151,198 43,885 Mar 06 07:05 PM Lillis Terrance Director Oct 27 '23 Buy 22.86 1,000 22,865 4,000 Oct 31 04:55 PM Lillis Terrance Director May 17 '23 Buy 26.39 1,000 26,390 3,000 May 18 06:14 PM Subramaniam Shivan S. Director Apr 21 '23 Buy 28.79 3,300 95,007 66,263 Apr 24 05:00 PM
Category Global or ExUS Equities - Factor & Thematic
Asset Type Equities (Stocks)
Tags Global
Return% 1Y -
Shs Outstand
Perf Week -1.33%
Sponsor KB AM
ETF Type
Tags equity
Return% 3Y -
Total Holdings 38
Perf Month -3.54%
Fund Family
Bond Type
Tags technology
Return% 5Y -
AUM 6.59M
Perf Quarter 0.47%
Index INDXX Global Battery Recycling & Product...
Average Maturity
Tags innovation
Return% 10Y
NAV%
Perf Half Y -
Index Weighting
Commodity Type
Tags batteries
Return% SI
NAV/sh
Perf Year -
Active/Passive
Quant Type
Tags -
Flows% 1M 0.00%
52W Range 21.95 - 26.08
Perf YTD -8.77%
Dividend TTM -
ESG Type
Tags -
Flows% 3M 11.56%
52W High -10.05%
Beta -
Dividend Ex-Date Jan 28, 2021
Dividend Type
Sector/Theme
Flows% YTD 123.44%
52W Low 6.88%
ATR (14) 0.21
Expense 0.65%
Structure Type
Region
Flows% 1Y
RSI (14) 43.62
Volatility 0.41% 0.17%
Option/Short No / Yes
Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 0.01
Prev Close 23.48
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 1.42K
Price 23.46
SMA20 -2.22%
SMA50 0.06%
SMA200 -0.80%
Trades
Volume 9
Change -0.08%
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite